Cutler Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Cutler Group’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-155	Closed	-$1K	–	5411
2020 Q2	$1K	Hold	155	–	–	﹤0.01%	4237
2020 Q1	$0	Sell	155 -185	-54%	-$1.99K	﹤0.01%	4866
2019 Q4	$4K	Hold	340	–	–	﹤0.01%	3197
2019 Q3	$3K	Hold	340	–	–	﹤0.01%	3395
2019 Q2	$5K	Hold	340	–	–	﹤0.01%	3156
2019 Q1	$11K	Hold	340	–	–	﹤0.01%	2452
2018 Q4	$9K	Hold	340	–	–	﹤0.01%	2622
2018 Q3	$20K	Hold	340	–	–	﹤0.01%	2249
2018 Q2	$25K	Hold	340	–	–	﹤0.01%	2048
2018 Q1	$22K	Sell	340 -498	-59%	-$37.6K	﹤0.01%	2233
2017 Q4	$70K	Buy	838 +76	+10%	+$7.45K	﹤0.01%	1621
2017 Q3	$87K	Buy	762 +614	+415%	+$64.6K	﹤0.01%	1782
2017 Q2	$17K	Sell	148 -1,432	-91%	-$178K	﹤0.01%	3613
2017 Q1	$194K	Buy	1,580 +1,540	+3,850%	+$202K	0.01%	1220
2016 Q4	$5K	Sell	40 -290	-88%	-$51.5K	﹤0.01%	4980
2016 Q3	$65K	Sell	330 -328	-50%	-$56.5K	﹤0.01%	2208
2016 Q2	$85K	Sell	658 -1,004	-60%	-$112K	﹤0.01%	1841
2016 Q1	$155K	Sell	1,662 -180	-10%	-$19.6K	0.01%	1204
2015 Q4	$373K	Buy	+1,842	New	+$330K	0.02%	784

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cutler Group's BLCM Position: Q3 2020 in Review

Cutler Group sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2020, closing a stake of 155 shares — an estimated $1K sold.

Cutler Group first reported a position in BLCM in Q4 2015 and held it in 19 quarters. The position peaked at $373K in Q4 2015. 22 funds tracked by Wall St. Rank hold BLCM as of Q3 2020.

Cutler Group reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Cutler Group sold 155 Bellicum Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1K.
Cutler Group first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2015 and held it in 19 quarters.
Cutler Group's Bellicum Pharmaceuticals, Inc. position peaked at $373K in Q4 2015.
22 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2020.

Based on Cutler Group's 13F filing for Q3 2020, filed 27 Oct 2020.